SSADH deficiency describes a rare neurometabolic disease that causes global developmental delay, intellectual disability, hypotonia, and behavioral abnormalities, often classified as an autistic spectrum disorder. This evidence concerns the gene ALDH5A1 and glycogen storage disease VI.